Walter Choung, MD
Orthopaedic Surgery · Beverly Hills, FLNPI 1740232917
Payments from drug & device makers
Across 26 payments — averaging $20.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CGG Medical Inc$85
- Smith+Nephew$52
- Johnson & Johnson$45
- Dynasplint Systems Inc.$45
- Heron Therapeutics, Inc.$43
- Pacira Therapeutics, Inc.$43
- plus $218 from 10 others
What the payments were for
- Food & beverage$531100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CGG Medical Inc | 3 | $85 |
| Smith+Nephew | 2 | $52 |
| Johnson & Johnson(2 entities) | 2 | $45 |
| Dynasplint Systems Inc. | 1 | $45 |
| Heron Therapeutics, Inc. | 3 | $43 |
| Pacira Therapeutics, Inc. | 2 | $43 |
| Vertex | 2 | $39 |
| Bioventus LLC | 2 | $34 |
| Stryker | 1 | $29 |
| Pacira Pharmaceuticals Incorporated | 2 | $27 |
| Amgen | 1 | $20 |
| Vericel Corporation | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Sanara Medtech Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $12 |
How this compares
$531 in reported general payments places this provider in the 15th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 298 | $2,897 |
| Meloxicam | 544 | $2,044 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 168 | $1,618 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 217 | $1,030 |
| Tramadol Hcl | 130 | $494 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 60 | $480 |
| Cyclobenzaprine Hcl | 45 | $454 |
| Promethazine Hcl | 17 | $311 |
| Cephalexin | 24 | $139 |
| Ciprofloxacin Hcl | 13 | $125 |
| Zolpidem Tartrate | 18 | $99 |
| Ibuprofen | 16 | $85 |
| Oxycodone Hcl | 18 | $46 |
| Carisoprodol | 11 | $34 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Beverly Hills
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$35M
- Mark FrankleTemple Terrace$31.4M
- David WatsonTemple Terrace$21M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Martin RocheFt. Lauderdale$7.3M
- Robert SantrockFernandina Beach$7.3M
- Steven LyonsTampa$6.8M
- Derek CuffVenice$6.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.